Certified by Founder Lodge
Resalis Therapeutics
Italy - Turin, Piedmont
START UP
1 Disclosed Funding Rounds $10,952,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease.
The company is applying its unique
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 08 ,2024 | Pre Series A | $10,952,000 |
Sunstone Life Science Ventures
Claris Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Tutor | $34,000,000 | (Dec 2, 2025)
Jeeva AI | $9,000,000 | (Dec 2, 2025)
Black Forest Labs | $300,000,000 | (Dec 2, 2025)
Raindrop | $15,000,000 | (Dec 2, 2025)
Mixx Technologies Inc | $33,000,000 | (Dec 2, 2025)
